MedPath

OLANZAPINA TEVA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

OLANZAPINA TEVA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

107427001

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Aug 2, 2024

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number107427001
EMA Approved
Yes

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

OLANZAPINAActive
Quantity: 2,5 mg
Name: OLANZAPINA

ATC CLASSIFICATION (3)

N05A
N05AH
N05AH03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.